CD274 and cancer: The significantly enriched pathways included PD-L1 expression, the PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway, natural killer cell-mediated cytotoxicity, cytokine-cytokine receptor interaction, and the differentiation of Th17 cell.